Key numbers

  • Model status

    Not released

    Best candidate fda_iq@0.5.0: 3 of 9 release checks passed

    How estimates work

  • Drugs tracked

    711

    In the drug database, listings not yet reviewed included

  • Upcoming PDUFAs

    4

    Next 30 days

  • FDA decisions

    2

    Novel first-cycle decisions, last 30 days

Upcoming PDUFA dates

PDUFA dates in the next 30 days, soonest first
Drug / tickerCT-VCAP(Approve)PDUFADays to goWatchlist
CemdisiranREGN Generalized myasthenia gravis (gMG) No published CT-VCA scoreNot released: no approval estimate is shown28 days left in the periodDate not exact Sign in to save Cemdisiran to a watchlist
BXCL501Not yet reviewed: Listed from FDA or ClinicalTrials.gov records; an editor has not checked it yetBTAIQ Agitation,Psychomotor, Bipolar I Disorder, Bipolar II Disorder, Schizoaffective Disorder, Schizophrenia No published CT-VCA scoreNot released: no approval estimate is shown12 days to go Sign in to save BXCL501 to a watchlist
IvonescimabNot yet reviewed: Listed from FDA or ClinicalTrials.gov records; an editor has not checked it yetSMMT Non-Small Cell Lung Cancer, Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma (UC) No published CT-VCA scoreNot released: no approval estimate is shown12 days to go Sign in to save Ivonescimab to a watchlist
PovetaciceptVRTX IgA nephropathy (IgAN) No published CT-VCA scoreNot released: no approval estimate is shown28 days to go Sign in to save Povetacicept to a watchlist

Dates come from company and FDA disclosures and can change. P(Approve) stays “Not released” until a model passes its release checks. How estimates work

Model release checks

FDA approval model (FDA IQ)
Not released
Best candidate
fda_iq@0.5.0 sha256:0b83ea99…f233c
Release checks passed
3 of 9 release checks passed
Status
Serving blocked: no model has passed the release gates; the best candidate passes 3 of 9.

Estimates appear only after a model passes all nine release checks on past FDA decisions and a second admin approves it. Until then no drug shows a probability, a range or a confidence level.

Recent FDA decisions

All decisions

Data provided by the U.S. Food and Drug Administration. Facts only: no estimate is shown for past decisions.

Health News Breaking and top news, sector and specialty news, Health Market, experts and opinions, Health Investor, the FDA calendar and AlphaDoc.

FDA safety alerts

View all FDA safety alerts

Daily Pulse

Free morning email

Upcoming FDA dates and the latest health headlines each morning, each item linked to its source.

Create a free account to choose your feeds and send time.

Recent insider trades

All insider trades
  • Other
    Brennan Daniel J.

    Director, VRTX

    $400.3K795 shares

  • Sell
    Malik Fady Ibraham

    EVP Research & Development, CYTK

    $224K3,500 shares

  • Other
    Malik Fady Ibraham

    EVP Research & Development, CYTK

    $27.3K3,500 shares

  • Other
    Sulzberger Gabrielle

    Director, LLY

    $5K3.9976 shares

  • Other
    LUCIANO JUAN R

    Director, LLY

    $15.9K12.8325 shares

Form 4 filings from SEC EDGAR. Insider filings are public records and are not a recommendation.

Health Deals

All deals